Sehr T - Search Results

1

Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study.

Sehr T, Akgün K, Proschmann U, Bucki R, Zendzian-Piotrowska M, Ziemssen T. Sehr T, et al. J Mol Med (Berl). 2019 Sep;97(9):1263-1271. doi: 10.1007/s00109-019-01812-x. Epub 2019 Jun 26. J Mol Med (Berl). 2019. PMID: 31243520

2

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.

Sehr T, Proschmann U, Thomas K, Marggraf M, Straube E, Reichmann H, Chan A, Ziemssen T. Sehr T, et al. J Neuroinflammation. 2016 Jun 27;13(1):164. doi: 10.1186/s12974-016-0635-2. J Neuroinflammation. 2016. PMID: 27349895 Free PMC article.

3

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation.

Thomas K, Sehr T, Proschmann U, Rodriguez-Leal FA, Haase R, Ziemssen T. Thomas K, et al. Among authors: sehr t. J Neuroinflammation. 2017 Feb 23;14(1):41. doi: 10.1186/s12974-017-0817-6. J Neuroinflammation. 2017. PMID: 28231856 Free PMC article.

4

Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".

Sehr T, Proschmann U, Thomas K, Ziemssen T. Sehr T, et al. Mult Scler. 2018 May;24(6):820-822. doi: 10.1177/1352458517726384. Epub 2017 Aug 14. Mult Scler. 2018. PMID: 28805095 No abstract available.

5

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.

Ziemssen T, Tumani H, Sehr T, Thomas K, Paul F, Richter N, Samara E, Spiegelstein O, Sorani E, Bar-Ilan O, Mimrod D, Hayardeny L. Ziemssen T, et al. Among authors: sehr t. J Neuroinflammation. 2017 Aug 31;14(1):172. doi: 10.1186/s12974-017-0945-z. J Neuroinflammation. 2017. PMID: 28859672 Free PMC article. Clinical Trial.

6

Letter to the editor regarding "Therapeutic drug monitoring of natalizumab".

Proschmann U, Sehr T, Akgün K, Ziemssen T. Proschmann U, et al. Among authors: sehr t. Mult Scler. 2020 May;26(6):741-742. doi: 10.1177/1352458519837702. Epub 2019 Apr 3. Mult Scler. 2020. PMID: 30943104 No abstract available.

7

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration.

Sehr T, Akgün K, Haase R, Ziemssen T. Sehr T, et al. Front Neurol. 2020 May 12;11:391. doi: 10.3389/fneur.2020.00391. eCollection 2020. Front Neurol. 2020. PMID: 32477253 Free PMC article.

8

Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance.

Sehr T, Akgün K, Benkert P, Kuhle J, Ziemssen T, Brandt MD. Sehr T, et al. J Sleep Res. 2024 Oct;33(5):e14164. doi: 10.1111/jsr.14164. Epub 2024 Feb 13. J Sleep Res. 2024. PMID: 38351662

9

A pragmatic methodical framework for the user-centred development of an electronic process support for the sleep laboratory patients' management.

Zerlik M, Jung IC, Sehr T, Hennings F, Kamann C, Brandt MD, Sedlmayr M, Sedlmayr B. Zerlik M, et al. Among authors: sehr t. Digit Health. 2022 Oct 26;8:20552076221134437. doi: 10.1177/20552076221134437. eCollection 2022 Jan-Dec. Digit Health. 2022. PMID: 36325436 Free PMC article.

10

State-of-the-art sleep arousal detection evaluated on a comprehensive clinical dataset.

Ehrlich F, Sehr T, Brandt M, Schmidt M, Malberg H, Sedlmayr M, Goldammer M. Ehrlich F, et al. Among authors: sehr t. Sci Rep. 2024 Jul 14;14(1):16239. doi: 10.1038/s41598-024-67022-9. Sci Rep. 2024. PMID: 39004643 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters